Moving to new premises in Vantaa strengthened our operational reliability
In autumn 2022, we moved our manufacture, laboratory, storage and support services to the new headquarters in Vantaa. The new premises has a staff of 300.
Moving to Vantaa was not just about having new premises, it also meant the introduction of new and innovative technology, such as automated laboratory and storage systems. The result is smoother and faster processes to the benefit of the hospitals and patients who need our products and services.
New technology is also utilized in our cell production centre, which manufactures advanced cell therapy products for the treatment of severe illnesses. The new technology and production premises will boost the development of these products.
The new premises are an investment in the future and will further improve the reliability of our blood product services. Our level of preparedness has been improved in many ways, one example being the bolstering of reserve power.
The building techniques employed in the new premises provide not just for the Blood Service’s specific requirements but also take into account environmental impact issues and energy efficiency (e.g. adjustable ventilation, condensation heat recovery, LED lighting and sun protection for the windows). The building has been awarded an international LEED Silver environmental certificate.
The new premises were built by Hartela Oy. Construction work began in summer 2020 and was completed in summer 2022. The building is owned by the real estate investment company Fastighets Ab Balder and rented by the Blood Service.
